State Street Corp Cullinan Oncology, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, State Street Corp holds 2,337,222 shares of CGEM stock, worth $25.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,337,222

Previous 1,941,188 20.4%

Holding current value

$25.6 Million

Previous $33.9 Million 15.57%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$16.03 - $20.86 $6.35 Million - $8.26 Million	396,034 Added 20.4%	2,337,222 $39.1 Million
Q2 2024 Aug 14, 2024	BUY	$15.63 - $29.35 $8.06 Million - $15.1 Million	515,729 Added 36.18%	1,941,188 $33.9 Million
Q1 2024 May 15, 2024	BUY	$10.17 - $19.02 $8.75 Million - $16.4 Million	860,055 Added 152.11%	1,425,459 $24.3 Million
Q4 2023 Feb 14, 2024	BUY	$7.89 - $10.23 $343,278 - $445,086	43,508 Added 8.34%	565,404 $5.76 Million
Q3 2023 Nov 14, 2023	SELL	$9.05 - $11.72 $2,941 - $3,809	-325 Reduced 0.06%	521,896 $4.72 Million
Q2 2023 Aug 14, 2023	SELL	$8.8 - $13.4 $351,938 - $535,906	-39,993 Reduced 7.11%	522,221 $5.62 Million
Q1 2023 May 15, 2023	BUY	$10.2 - $11.91 $80,202 - $93,648	7,863 Added 1.42%	562,214 $5.75 Million
Q4 2022 Feb 14, 2023	BUY	$9.72 - $13.62 $513,556 - $719,612	52,835 Added 10.54%	554,351 $5.85 Million
Q3 2022 Nov 15, 2022	BUY	$11.82 - $15.42 $320,180 - $417,696	27,088 Added 5.71%	501,516 $6.43 Million
Q2 2022 Aug 15, 2022	SELL	$7.31 - $13.55 $4.44 Million - $8.23 Million	-607,109 Reduced 56.13%	474,428 $6.08 Million
Q1 2022 May 16, 2022	SELL	$10.47 - $16.75 $982,358 - $1.57 Million	-93,826 Reduced 7.98%	1,081,537 $11.3 Million
Q4 2021 Feb 14, 2022	BUY	$15.36 - $25.0 $12.5 Million - $20.3 Million	812,404 Added 223.83%	1,175,363 $18.1 Million
Q3 2021 Nov 15, 2021	BUY	$22.56 - $29.68 $3.05 Million - $4.01 Million	135,116 Added 59.3%	362,959 $8.19 Million
Q2 2021 Aug 16, 2021	BUY	$24.96 - $41.25 $824,378 - $1.36 Million	33,028 Added 16.95%	227,843 $5.87 Million
Q1 2021 May 17, 2021	BUY	$28.0 - $53.42 $5.45 Million - $10.4 Million	194,815 New	194,815 $8.12 Million

Others Institutions Holding CGEM

# of Institutions

146

Shares Held

67.6M

Call Options Held

612K

Put Options Held

118K

View Full List

About Cullinan Oncology, Inc.

Ticker CGEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,612,200
Market Cap $499M
Description
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...

More about CGEM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Cullinan Oncology, Inc. Transaction History